E
Eagle Genomics
Developing life sciences smart data management and analysis solutions
About Eagle Genomics
Eagle Genomics is a pioneering company operating at the intersection of life sciences and data science. The company specializes in leveraging big data to unlock the potential of the microbiome, which is the community of microorganisms living in various environments, including the human body. By utilizing advanced data analytics and artificial intelligence, Eagle Genomics helps its clients understand and harness the power of microbiomes to drive innovation and improve outcomes in health, agriculture, and other sectors.
Read full description
The company primarily serves clients in the life sciences industry, including biotechnology firms, pharmaceutical companies, and agricultural businesses. One notable client is Cargill, a global food corporation, with whom Eagle Genomics has entered into a multi-year platform engagement. This partnership underscores the company's ability to deliver scalable and impactful solutions.
Eagle Genomics operates in the rapidly growing market of microbiome research and data analytics. This market is driven by the increasing recognition of the microbiome's role in health and disease, as well as its potential applications in agriculture and other industries.
The business model of Eagle Genomics revolves around its proprietary platform, which integrates and analyzes complex microbiome data. Clients subscribe to this platform to gain insights that can drive their research and development efforts. The company generates revenue through these subscription fees, as well as through bespoke data analysis services and long-term partnerships.
In summary, Eagle Genomics is a data-driven company that empowers life sciences organizations to explore and exploit the microbiome's potential. By providing cutting-edge analytics and insights, the company helps its clients innovate and achieve better outcomes.
At a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Cambridge, United Kingdom
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 72.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Recycling, Open Source, Analytics, Cloud Computing, Biotechnology, Oncology, DNA, Clinical, Genetics and genomics
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Sep 2023 | $4M | $100M | ETF Partners · Granpool · Aberdeen | ↗ |
| EARLY VC✓Equity / VC | Jan 2023 | — | — | Omron Ventures · Aberdeen · ETF Partners · Granpool | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Eagle Genomics is 150 monthly website visits, down 92.1% over the last three months. Eagle Genomics's team declined 6.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed10 investors entered at this stage
Cambridge Capital Group
UK Innovation & Science Seed Fund
London Business Angels
Cambridge Angels
Jonathan Milner
ACF Investors
Pitch@Palace
Newable Private Investing- AMAngels in MedCity
Future Planet Capital
Series A6 investors entered at this stage
ETF Partners- BPBpd partners
Granpool- ABAlbert László Barabasi
Aberdeen
Omron Ventures
Other known investors6 additional known investors
Tech Nation
Andrew Levi
Cristian Hernandez-Cuevas
EIT Food
GROW
Omron Electronics
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Eagle Genomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Eagle Genomics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.